Botox. It's more than just a wrinkle buster By: CNBC.com News April 22, 2014 at 14:18 PM EDT More than half of the revenue from Botox comes from therapeutic uses, not cosmetic ones. And its potential is helping to make Allergan an attractive target. Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.